Literature DB >> 8235704

Axl, a novel receptor tyrosine kinase isolated from chronic myelogenous leukemia.

A Neubauer1, J P O'Bryan, A Fiebeler, C Schmidt, D Huhn, E T Liu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8235704

Source DB:  PubMed          Journal:  Semin Hematol        ISSN： 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  8 in total

1.  Paradoxical role of the proto-oncogene Axl and Mer receptor tyrosine kinases in colon cancer.

Authors:  Lidia Bosurgi; Jochem H Bernink; Victor Delgado Cuevas; Nicola Gagliani; Leonel Joannas; Edward T Schmid; Carmen J Booth; Sourav Ghosh; Carla V Rothlin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-22       Impact factor: 11.205

2.  Differential expression of CRKL and AXL genes in lung adenocarcinoma subtypes according to the epidermal growth factor receptor and anaplastic lymphoma kinase gene status.

Authors:  DA-Ping Yu; Yu-Jie Dong; Hai-Qing Zhang; Jing-Hui Wang; Yang Qu; Li-Juan Zhou; Dan Su; Li-Li Zhang; Dan Zhao; Yi-Ran Cai
Journal:  Biomed Rep       Date:  2014-03-20

3.  ABL regulation by AXL promotes cisplatin resistance in esophageal cancer.

Authors:  Jun Hong; Dunfa Peng; Zheng Chen; Vikas Sehdev; Abbes Belkhiri
Journal:  Cancer Res       Date:  2012-11-01       Impact factor: 12.701

4.  The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target.

Authors:  Jan-Bart M Koorstra; Collins A Karikari; Georg Feldmann; Savita Bisht; Pamela Leal Rojas; G Johan A Offerhaus; Hector Alvarez; Anirban Maitra
Journal:  Cancer Biol Ther       Date:  2009-04-22       Impact factor: 4.742

Review 5.  Advances in targeted therapies and new promising targets in esophageal cancer.

Authors:  Abbes Belkhiri; Wael El-Rifai
Journal:  Oncotarget       Date:  2015-01-30

6.  Reversal of Cisplatin resistance by epigallocatechin gallate is mediated by downregulation of axl and tyro 3 expression in human lung cancer cells.

Authors:  Kyung-Chan Kim; Chuhee Lee
Journal:  Korean J Physiol Pharmacol       Date:  2014-02-13       Impact factor: 2.016

7.  Inactivation of GSK3β and activation of NF-κB pathway via Axl represents an important mediator of tumorigenesis in esophageal squamous cell carcinoma.

Authors:  Juliano D Paccez; Kristal Duncan; Akhona Vava; Ricardo G Correa; Towia A Libermann; M Iqbal Parker; Luiz F Zerbini
Journal:  Mol Biol Cell       Date:  2015-01-07       Impact factor: 4.138

8.  Identification of potential target genes associated with the effect of propranolol on angiosarcoma via microarray analysis.

Authors:  Shiyong Zhou; Pengfei Liu; Wenhua Jiang; Huilai Zhang
Journal:  Oncol Lett       Date:  2017-03-31       Impact factor: 2.967
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.